The story of Viagra, and its creator copyright, presents a intriguing case study for investors. Originally a blockbuster drug, yielding billions in revenue , its exclusivity period created a flood of generic competition , significantly eroding its dominance. While certain pharmaceutical companies may seek to capitalize on male sexual dysfunction… Read More